20038864

Source:http://linkedlifedata.com/resource/pubmed/id/20038864

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0600518, umls-concept:C1417579, umls-concept:C1517572, umls-concept:C1522701, umls-concept:C1566537, umls-concept:C1656863
pubmed:issue	3
pubmed:dateCreated	2010-3-10
pubmed:abstractText	The purpose of this study was to evaluate the efficacy of intravitreal injections of ranibizumab in choroidal neovascularization secondary to pathologic myopia.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309919
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Coloring Agents, http://linkedlifedata.com/resource/pubmed/chemical/Indocyanine Green, http://linkedlifedata.com/resource/pubmed/chemical/ranibizumab
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1539-2864
pubmed:author	pubmed-author:Bastuji-GarinSylvieS, pubmed-author:CoscasGabrielG, pubmed-author:Glacet-BernardAgnesA, pubmed-author:LalloumFranckF, pubmed-author:LevezielNicolasN, pubmed-author:PucheNathalieN, pubmed-author:QuerquesGiuseppeG, pubmed-author:SoubraneGiseleG, pubmed-author:SouiedEric HEH
pubmed:issnType	Electronic
pubmed:volume	30
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	399-406
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:20038864-Adult, pubmed-meshheading:20038864-Aged, pubmed-meshheading:20038864-Aged, 80 and over, pubmed-meshheading:20038864-Angiogenesis Inhibitors, pubmed-meshheading:20038864-Antibodies, Monoclonal, pubmed-meshheading:20038864-Antibodies, Monoclonal, Humanized, pubmed-meshheading:20038864-Choroidal Neovascularization, pubmed-meshheading:20038864-Coloring Agents, pubmed-meshheading:20038864-Female, pubmed-meshheading:20038864-Fluorescein Angiography, pubmed-meshheading:20038864-Follow-Up Studies, pubmed-meshheading:20038864-Humans, pubmed-meshheading:20038864-Indocyanine Green, pubmed-meshheading:20038864-Injections, pubmed-meshheading:20038864-Male, pubmed-meshheading:20038864-Middle Aged, pubmed-meshheading:20038864-Myopia, Degenerative, pubmed-meshheading:20038864-Prospective Studies, pubmed-meshheading:20038864-Tomography, Optical Coherence, pubmed-meshheading:20038864-Treatment Outcome, pubmed-meshheading:20038864-Visual Acuity, pubmed-meshheading:20038864-Vitreous Body
pubmed:year	2010
pubmed:articleTitle	Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia.
pubmed:affiliation	Department of Ophthalmology, Centre Hospitalier Intercommunal de Creteil, France.
pubmed:publicationType	Journal Article